BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

PURPOSE: To investigate the prognostic value of the BRAF V600E mutation and the recently identified TERT promoter mutation chr5:1,295,228C>T (C228T), individually and in their coexistence, in papillary thyroid cancer (PTC). PATIENTS AND METHODS: We performed a retrospective study of the relations...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xing, Mingzhao, Liu, Rengyun, Liu, Xiaoli, Murugan, Avaniyapuram Kannan, Zhu, Guangwu, Zeiger, Martha A., Pai, Sara, Bishop, Justin
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2014
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145183/
https://ncbi.nlm.nih.gov/pubmed/25024077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.5094
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items